HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Is atypical adenomatous hyperplasia of the prostate a precursor lesion?

AbstractBACKGROUND:
Alpha-methylacyl-CoA racemase (AMACR) is highly expressed in prostatic adenocarcinoma. The precursor nature of atypical adenomatous hyperplasia (AAH) is uncertain.
METHODS:
One hundred twenty-one AAH foci from 101 patients who underwent transurethral prostatic resection or prostatectomy were immunohistochemically analyzed for AMACR, high molecular weight cytokeratin 34βE12, and p63 expression by a triple antibody (PIN4) cocktail stain.
RESULTS:
Sixty-eight foci (56%) of AAH showed no AMACR immunostaining. Fourteen cases (12%) showed weak AMACR immunoreactivity in 1-9% of lesional cells. Sixteen cases (13%) showed strong immunopositivity for AMACR in >50% of lesional cells. AMACR expression in AAH was significantly higher in cases in which coexisting PCA was present, compared with its expression in AAH foci without coexisting PCA (P = 0.03). Strong diffuse AMACR positivity in over 50% of lesional cells was seen almost exclusively in AAH foci with coexisting PCA (P = 0.002). AMACR expression in AAH showed no correlation with patient age (P = 0.38), specimen type (P = 0.35), prostate weight (P = 0.80), zonal location (P = 0.50), distance to cancer (P = 0.28), Gleason score (P = 0.06), or pathologic stage (P = 0.23). Increased AMACR expression showed a negative correlation with the size of AAH foci (P = 0.03). All AAH lesions showed fragmented basal cell layers, highlighted by p63 and high molecular weight cytokeratin staining.
CONCLUSIONS:
A significant percentage of AAH cases show stronger and more extensive AMACR expression when associated with prostatic adenocarcinoma, as compared to AAH foci found without coexisting prostate cancer. Our data provide additional evidence linking AAH to prostatic adenocarcinoma.
AuthorsChen Zhang, Rodolfo Montironi, Gregory T MacLennan, Antonio Lopez-Beltran, Yan Li, Puay-Hoon Tan, Mingsheng Wang, Shaobo Zhang, Kenneth A Iczkowski, Liang Cheng
JournalThe Prostate (Prostate) Vol. 71 Issue 16 Pg. 1746-51 (Dec 2011) ISSN: 1097-0045 [Electronic] United States
PMID21480308 (Publication Type: Journal Article)
CopyrightCopyright © 2011 Wiley Periodicals, Inc.
Chemical References
  • Biomarkers, Tumor
  • Racemases and Epimerases
  • alpha-methylacyl-CoA racemase
Topics
  • Adenocarcinoma (metabolism, pathology)
  • Adult
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor (metabolism)
  • Diagnosis, Differential
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Grading
  • Organ Size
  • Precancerous Conditions (metabolism, pathology)
  • Prostatic Hyperplasia (metabolism, pathology)
  • Prostatic Neoplasms (metabolism, pathology)
  • Racemases and Epimerases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: